The Antibody Drug Conjugate (ADC) industry is poised for a transformative leap, with a surge of deals, innovations, and collaborations spotlighting Asia as the hub for next-generation ADC development.
ON Helix is the annual showcase of Life Sciences in the Eastern Region. One Nucleus never fails to deliver a fantastic conference with top tier speakers who give insightful views into challenges and trends which are current in the sector.
This year, the summit features a revamped agenda packed with in-depth case studies on cytotoxic compound development, process collaboration, and safe scale-up strategies.
